Shanghai Listent Medical Technology Co., Ltd. (Listent) was established in June 2004. The company was established on the basis of the achievements of cochlear implant project in the EYE & ENT Hospital of Fudan University, Shanghai Institute of auditory medicine and Key Laboratory of auditory medicine of the Ministry of health. Shanghai Listent Medical Tech Co.,Ltd specializes in the research and development of high-end medical devices for cochlear implant. The company is an innovative high-tech enterprise integrating "production, academic, research and medicine". It is located in the core Park of Zhangjiang Science City, Shanghai International Medical Park. The company's registered capital is RMB 164.69 million, and the controlling shareholder is Xinxing Cathay International Group Co., Ltd.

 

In 2005, Listent company launched the model REZ-I cochlear implant, which established China's first technical standard for cochlear implants. In 2011, the company obtained China's first cochlear implant product registration certificate. On May 15, 2019, Listent company's new-generation cochlear implant LCI-20PI, which took 7 years to develop, obtained the registration certificate of the State Drug Administration of China. So far, the performance indexes of Chinese cochlear implant technology have reached the international advanced level.